Pharmacogenomics of MDR1/ABCB1 Gene: the Influence on Risk and Clinical Outcome of Haematological Malignancies

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Hematology

• Publication date

  2004-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/10245330310001638974PMID 15203864
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• P-glycoprotein-expressing tumor cells are resistance to anticancer drugs in human gastrointestinal cancer

  2006cited by this paper
• Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients

  2005cited by this paper
• Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia

  2004cited by this paper
• Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis.

  2003cited by this paper
• The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min/+) mice.

  2003cited by this paper
• Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients.

  2003cited by this paper
• Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1.

  2003cited by this paper
• Human MDR1 polymorphism: G2677T/A and C3435T have no effect on MDR1 transport activities.

  2003cited by this paper
• MDR1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytes

  2003cited by this paper
• Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms

  2003cited by this paper
• Frequency Distribution of C3435T Mutation in Exon 26 of the MDR1 Gene in a Spanish Population

  2003cited by this paper
• MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients

  2003cited by this paper
• The Effect of CYP3A5 and MDR1 Polymorphic Expression on Cyclosporine Oral Disposition in Renal Transplant Patients

  2003cited by this paper
• The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in ApcMin/+ mice

  2003cited by this paper
• Simultaneous genotyping of seven single-nucleotide polymorphisms in the MDR1 gene by single-tube multiplex minisequencing.

  2003cited by this paper
• Pharmacogenomics--drug disposition, drug targets, and side effects.

  2003cited by this paper
• Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.

  2003cited by this paper
• Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene.

  2003cited by this paper
• Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.

  2003cited by this paper
• Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic-genotypic correlates.

  2003cited by this paper
• MDR1 Genotype-Related Duodenal Absorption Rate of Digoxin in Healthy Japanese Subjects

  2003cited by this paper
• Digoxin pharmacokinetics and MDR1 genetic polymorphisms

  2003cited by this paper
• Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer.

  2003cited by this paper
• Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system.

  2002cited by this paper
• Influence of functional MDR1 gene polymorphisms on P-glycoprotein activity in CD34+ hematopoietic stem cells.

  2002influential reference
• MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.

  2002cited by this paper
• Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia.

  2002cited by this paper
• Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720.

  2002cited by this paper
• MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia.

  2002cited by this paper
• Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors.

  2002influential reference
• C3435T Mutation in Exon 26 of the Human MDR1 Gene and Cyclosporine Pharmacokinetics in Healthy Subjects

  2002cited by this paper
• SNPper: retrieval and analysis of human SNPs

  2002cited by this paper
• Functional MDR1 polymorphisms (G2677T and C3435T) and TCF4 mutations in colorectal tumors with high microsatellite instability.

  2002cited by this paper
• Distribution of allelic variants of functional C3435T polymorphism of drug transporter MDR1 gene in a sample of Polish population.

  2002cited by this paper
• Detection of MDR1 single nucleotide polymorphisms C3435T and G2677T using real-time polymerase chain reaction: MDR1 single nucleotide polymorphism genotyping assay

  2002cited by this paper
• The effects of the human MDR1 genotype on the expression of duodenal P‐glycoprotein and disposition of the probe drug talinolol

  2002cited by this paper
• ABC Transporters as Phenotypic Markers and Functional Regulators of Stem Cells

  2002cited by this paper
• The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients.

  2002cited by this paper
• Effects of polymorphisms of MDR1, MRP1, and MRP2 genes on their mRNA expression levels in duodenal enterocytes of healthy Japanese subjects.

  2002cited by this paper
• C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation.

  2002cited by this paper
• A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression

  2002influential reference
• Biology and modulation of multidrug resistance (MDR) in hematological malignancies

  2002cited by this paper
• Investigation of the coordinated functional activities of cytochrome P450 3A4 and P-glycoprotein in limiting the absorption of xenobiotics in Caco-2 cells.

  2002cited by this paper
• MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine.

  2002cited by this paper
• Significant Genetic Linkage of MDR1 Polymorphisms at Positions 3435 and 2677: Functional Relevance to Pharmacokinetics of Digoxin

  2002cited by this paper
• Allele frequency of three functionally active polymorphisms of the MDR-1 gene in high-risk HIV-negative and HIV-positive Caucasians.

  2002cited by this paper
• Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects

  2002cited by this paper
• Prolonged complete remission in two cases of acute promyelocytic leukaemia treated with atra alone

  2002cited by this paper
• Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease.

  2002cited by this paper
• Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.

  2002cited by this paper
• Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations.

  2002cited by this paper
• #21-S the role of MDR-1 gene polymorphisms in the genetic susceptibility to childhood leukemia

  2002cited by this paper
• Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects.

  2001cited by this paper
• MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity.

  2001cited by this paper
• The human ATP-binding cassette (ABC) transporter superfamily.

  2001cited by this paper
• Frequency of single nucleotide polymorphisms in the P‐glycoprotein drug transporter MDR1 gene in white subjects

  2001cited by this paper
• The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells.

  2001cited by this paper
• MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia.

  2001influential reference
• Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients

  2001cited by this paper
• No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients.

  2001cited by this paper
• Anti-P-Glycoprotein Antibody-Induced Apoptosis of Activated Peripheral Blood Lymphocytes: A Possible Role of P-Glycoprotein in Lymphocyte Survival

  2001cited by this paper
• Identification of functionally variant MDR1 alleles among European Americans and African Americans

  2001cited by this paper
• Drug resistance in hematologic malignancies

  2001cited by this paper
• MDR1 Genotype-Related Pharmacokinetics of Digoxin After Single Oral Administration in Healthy Japanese Subjects

  2001cited by this paper
• Frequency of C3435T polymorphism of MDR1 gene in African people.

  2001cited by this paper
• The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels

  2001cited by this paper
• Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene.

  2001cited by this paper
• Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers.

  2001cited by this paper
• The human ATP-binding cassette (ABC) transporter superfamily.

  2001cited by this paper
• A new polymorphism (N21D) in the exon 2 of the human MDR1 gene encoding the P‐glycoprotein

  2000cited by this paper
• Rapid detection of the C3435T polymorphism of multidrug resistance gene 1 using fluorogenic hybridization probes.

  2000cited by this paper
• Regulation of MDR1 gene expression: emerging concepts.

  2000cited by this paper
• P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin/cytosine arabinoside-based induction therapy

  2000cited by this paper
• P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway.

  2000cited by this paper
• Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.

  2000influential reference
• Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

  1999influential reference
• A mutation in the promoter of the multidrug resistance gene (MDR1) in human hematological malignancies may contribute to the pathogenesis of resistant disease.

  1999cited by this paper
• Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.

  1999cited by this paper
• Transport of the cooked-food mutagen 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) across the human intestinal Caco-2 cell monolayer: role of efflux pumps.

  1999cited by this paper
• Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors.

  1998cited by this paper
• Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia.

  1998cited by this paper
• A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels.

  1998cited by this paper
• The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis.

  1998cited by this paper
• Co-administration of cyclosporin enables oral therapy with paclitaxel.

  1998cited by this paper
• Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.

  1997cited by this paper
• Analysis of ion transport perturbations caused by hu MDR 1 protein overexpression.

  1997cited by this paper
• Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study.

  1997cited by this paper
• Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes.

  1996cited by this paper
• Multidrug resistance in Lactococcus lactis: evidence for ATP‐dependent drug extrusion from the inner leaflet of the cytoplasmic membrane.

  1996cited by this paper
• Expression of the multidrug resistance P glycoprotein in newly diagnosed adult acute lymphoblastic leukemia: absence of correlation with response to treatment.

  1995cited by this paper
• Point mutations in the mdr1 promoter of human osteosarcomas are associated with in vitro responsiveness to multidrug resistance relevant drugs.

  1994cited by this paper
• Phosphatidylcholine translocase: a physiological role for the mdr2 gene.

  1994cited by this paper
• Active transport of benzo[a]pyrene in apical membrane vesicles from normal human intestinal epithelium.

  1994cited by this paper
• P-glycoprotein expression and function in circulating blood cells from normal volunteers.

  1994cited by this paper
• Is the multidrug transporter a flippase?

  1992cited by this paper
• Pharmacology of drugs that alter multidrug resistance in cancer.

  1990cited by this paper
• Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins.

  1990cited by this paper
• P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance.

  1989cited by this paper
• Expression of Multidrug Resistance Gene in Human Cancers

  1989cited by this paper
• Phenotypic instability of drug sensitivity in a human colon carcinoma cell line.

  1989cited by this paper

• Pharmacogenomics Applied to Acute Leukemias: Identifying Clinically Relevant Genetic Variants

  2025cites this paper
• High-dose short-term osimertinib treatment is effective in patient-derived metastatic colorectal cancer organoids

  2024cites this paper
• MYEOV with High Frequencies of Mutations in Head and Neck Cancers Facilitates Cancer Cell Malignant Behaviors

  2023cites this paper
• Development of a Novel Tool To Demystify Drug Distribution at Tissue‐Blood Barriers

  2023cites this paper
• MDR1 rs1045642 Variant Is Linked with Lower Expression and Extends Overall Survival of Multiple Myeloma: A Hospital-Based Case-Control Study

  2023cites this paper
• Perioperative considerations in patients with chemotherapy-induced cognitive impairment: a narrative review.

  2022cites this paper
• Pharmacogenomics of Cancer Pain Treatment Outcomes in Asian Populations: A Review

  2022cites this paper
• Strategies to Suppress Tumor Angiogenesis and Metastasis, Overcome Multi-Drug Resistance in Cancer, Target Telomerase and Apoptosis Pathways

  2021cites this paper
• Structural and Functional Brain Imaging in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia Treated With Chemotherapy: A Systematic Review

  2021cites this paper
• Pharmacogenomics and personalized medicine in the treatment of human diseases

  2020cites this paper
• Impact of ABCB1 Gene (C3435T/A2677G) Polymorphic Sequence Variations on the Outcome of Patients with Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia in Kashmiri Population: A Case–Control Study

  2020cites this paper
• MDR 1 gene polymorphism in leukemia December 2019 Vol . 22 ( 10 ) Molecular effect MDR 1 ( C 3435 T ) gene polymorphism on leukemia patients in Babylon province , Iraq

  2020cites this paper
• Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo

  2017cites this paper
• Mitochondria do not play a major role in landomycin E-induced ROS burst and circumvention of multiple drug resistance in HL-60 leukemia cells

  2016cites this paper
• Targeting autophagy augments the activity of DHA-E3 to overcome p-gp mediated multi-drug resistance.

  2016cites this paper
• Impaired Brain Dopamine and Serotonin Release and Uptake in Wistar Rats Following Treatment with Carboplatin

  2016cites this paper
• Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.

  2016cites this paper
• Effect of Curcuminoids on MDR-1 Gene Expression in Multidrug Resistance Kbchr-8-5 Human Cervical Cancer Cell Line

  2016cites this paper
• Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma

  2016cites this paper
• Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells In Vitro, In Vivo, and Ex Vivo

  2016cites this paper
• IN VITRO EVALUATION OF ANTI-CANCER ACTIVITY OF CURCUMINOIDS FROM TURMERIC (CURCUMA LONGA L.) AGAINST MULTIDRUG RESISTANT TUMOR CELL LINES.

  2016cites this paper
• MDR1 C3435T and C1236T polymorphisms: association with high-risk childhood acute lymphoblastic leukemia.

  2015cites this paper
• MDR1/ABCB1 gene polymorphisms in patients with chronic myeloid leukemia

  2015influential citation
• Immunotoxins, Resistance and Cancer Stem Cells: Future Perspective

  2015cites this paper
• MDR 1 C 3435 T and C 1236 T Polymorphisms : Association with High-risk Childhood Acute Lymphoblastic Leukemia

  2015cites this paper
• Spiramine derivatives induce apoptosis of Bax(-/-)/Bak(-/-) cell and cancer cells.

  2014cites this paper
• Genotype and Allele Frequencies of MDR-1 Gene Polymorphism in Jordanian and Sudanese Populations

  2014cites this paper
• Genetic Susceptibility to Head and Neck Cancer

  2013cites this paper
• Pharmacogenetics of Chronic Pain and Its Treatment

  2013cites this paper
• BIRB796, the Inhibitor of p38 Mitogen-Activated Protein Kinase, Enhances the Efficacy of Chemotherapeutic Agents in ABCB1 Overexpression Cells

  2013cites this paper
• Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?

  2013cites this paper
• chronic-phase chronic myeloid leukemia after failure of imatinib therapy Dasatinib induces notable hematologic and cytogenetic responses in

  2013cites this paper
• The role of MDR1 (C3435T) gene polymorphism in Egyptian acute lymphoblastic leukemia

  2013cites this paper
• P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives.

  2013cites this paper
• A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk

  2012cites this paper
• MDR1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia

  2012cites this paper
• Gene-Wide Characterization of Common Quantitative Trait Loci for ABCB1 mRNA Expression in Normal Liver Tissues in the Chinese Population

  2012cites this paper
• The two enantiomers of tetrahydropalmatine are inhibitors of P-gp, but not inhibitors of MRP1 or BCRP

  2012cites this paper
• Interferon-alpha improves docetaxel antitumoral and antimetastatic efficiency in Lewis lung carcinoma bearing mice.

  2012cites this paper
• Neurocognitive Effects of Chemotherapy and Endocrine Therapies in the Treatment of Breast Cancer: Recent Perspectives

  2012cites this paper
• Evaluation of C3435T MDR1 Gene Polymorphism in Adult Patient with Acute Lymphoblastic Leukemia

  2011cites this paper
• Biodistribution and Pharmacokinetic Analysis of Combination Lonidamine and Paclitaxel Delivery in an Orthotopic Animal Model of Multi-drug Resistant Breast Cancer Using EGFR-Targeted Polymeric Nanoparticles

  2011cites this paper
• Up-regulation of ABCB1/P-glycoprotein by escaping promoter hypermethylation indicates poor prognosis in hematologic malignancy patients with and without bone marrow transplantation.

  2011cites this paper
• MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis

  2011cites this paper
• YC-1, a novel potential anticancer agent, inhibit multidrug-resistant protein via cGMP-dependent pathway

  2011cites this paper
• Evaluation of C 3435 T MDR 1 Gene Polymorphism in Adult Patient with Acute Lymphoblastic Leukemia

  2011cites this paper
• Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning

  2011cites this paper
• Impact of ABCB1 C3435T polymorphism on lymph node regression in multimodality treatment of locally advanced esophageal cancer.

  2011cites this paper
• Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.

  2011cites this paper
• Development of block copolymer based nanocarriers for the solubilization and delivery of valspodar

  2011cites this paper
• The Phosphodiesterase-5 Inhibitor Vardenafil Is a Potent Inhibitor of ABCB1/P-Glycoprotein Transporter

  2011cites this paper
• Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells.

  2011cites this paper
• Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer.

  2011cites this paper
• Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: results from the Malaysia-Singapore ALL Study Group.

  2010cites this paper
• Multidrug resistance in the chronic lymphoproliferative disorders

  2010cites this paper
• P-Glycoprotein Function at the Blood–Brain Barrier in Humans Can Be Quantified with the Substrate Radiotracer 11C-N-Desmethyl-Loperamide

  2010cites this paper
• Pharmacogenomics in the treatment of inflammatory bowel disease.

  2010cites this paper
• Tumor hypoxia, the Warburg effect, and multidrug resistance: Modulation of hypoxia induced MDR using EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine therapy

  2010cites this paper
• Pharmacogenomics and Personalized Medicine in the Treatment of Human Diseases

  2009cites this paper
• Genetic variations as cancer prognostic markers: review and update

  2009influential citation
• Cognitive function in breast cancer survivors.

  2009cites this paper
• Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.

  2009cites this paper
• Multi-functional nanocarriers for targeted delivery of drugs and genes.

  2008cites this paper
• Psorospermin structural requirements for P-glycoprotein resistance reversal

  2008cites this paper
• Identification and development of novel compounds for the treatment of human cancers

  2008cites this paper
• Association of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemia.

  2008influential citation
• High-Throughput Screening for Daunorubicin-Mediated Drug Resistance Identifies Mometasone Furoate as a Novel ABCB1-Reversal Agent

  2008cites this paper
• Genetic Polymorphisms and Head and Neck Cancer Outcomes: A Review

  2008cites this paper
• Multi-functional nanocarriers to overcome tumor drug resistance.

  2008cites this paper
• Oncology Group T-lineage acute lymphoblastic leukemia : a report from the Children ' s Identification of genomic classifiers that distinguish induction failure in

  2007cites this paper
• Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein).

  2007cites this paper
• The pharmacology of cancer resistance.

  2007cites this paper
• Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy.

  2007cites this paper
• Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group.

  2007cites this paper
• Candidate mechanisms for chemotherapy-induced cognitive changes

  2007cites this paper
• Pharmacogenetics: where are we with respect to personalized medicine?

  2007cites this paper
• Adaptive response to increased bile acids: induction of MDR1 gene expression and P-glycoprotein activity in renal epithelial cells

  2007cites this paper
• Update on pharmacogenetics in epilepsy: a brief review.

  2006cites this paper
• MDR1 gene polymorphisms and clinical relevance.

  2006cites this paper
• Pharmacogénétique des protéines de la famille MDR

  2005cites this paper
• Multi-drug transporter MDR1 gene polymorphism and prognosis in adult acute lymphoblastic leukemia.

  2005cites this paper
• Vincristine resistance development in lymphoblastoid cells under conditions of selective P-glycoprotein inhibition

  2005cites this paper
• Cancer Treatment and Research

  2005cites this paper
• Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.

  2005cites this paper
• Role of efflux pumps and metabolising enzymes in drug delivery

  2005cites this paper
• Drug Resistance and Its Clinical Circumvention

  2003cites this paper